Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The Global Hospital-acquired Disease Testing Market is segmented by Test Type (Urinary Tract Infection, Surgical Site Infection, Pneumonia, Blood Stream Infection, Methicillin-resistant Staphylococcus Aureus, and others) and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 925.4 million in 2019 and is projected to exhibit a CAGR of 20.0% over the forecast period (2019–2027).
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/992
According to the Centers for Disease Control and Prevention (CDC), 2016, about one in 25 hospital patients have at least one hospital-associated infection at any given day. They could be systemic, localized or can involve any system of the body. Reducing the incidence of hospital-acquired infections could help improve patient management. In 2017, around 11 samples of water were collected from Wide Bay hospital and Health service facilities in the U.S., out of which nine samples were found positive with Legionella which causes lung infection. Remediation measures such as chlorine and heat treatment, pipes and tape replacements, and disposal of water through proper systems need to be taken to curb the spread of these infections. According to BMJ journal, in 2012, healthcare-acquired diseases can be prevented. Medicare and private insurance companies are eliminating the reimbursement due to a high rate of hospital-acquired infections (HAI) during 2014 and 2015, adding economic pressure on countries. Hospital-acquired infections are usually caused when the shared equipment is not properly cleaned. Philips Healthcare is contributing towards management of hospital-acquired infections, which in turn increases the cost of disease testing and even leading to death of patients. The company provides single-patient use devices such as NIV masks, blood pressure cuffs, peripheral capillary oxygen saturation (Sp02) sensors, and ECG leads. These devices are designed to last for an entire day’s stay at the hospital.
Browse 33 Market Data Tables and 30 Figures spread through 140 Pages and in-depth TOC on Hospital-acquired Disease Testing Market by Test Type (Urinary Tract Infection, Surgical Site Infection, Pneumonia, Blood Stream Infection, Methicillin-resistant Staphylococcus Aureus, and others) and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) – Global Forecast to 2025
To know the latest trends and insights prevalent in the hospital-acquired disease testing market Press Release, click the link below: https://www.coherentmarketinsights.com/press-release/hospital-acquired-disease-testing-market-to-surpass-us-27-billion-by-2025-globally-424
In 2017, Patrona Medical and Kopis developed a medical device using Zipit’s loT platform and announced its collaboration with Patrona Medical’s Foley Garde solution. Foley Grade Solutions — a company focused on improved care and mediation associated with hospital-acquired infections – created an automated interface to assist timely detection of catheters which are a major cause of urinary tract infections. Furthermore, the interface reduces costs associated with the infection. A new device, known as Surfaceskins was developed to combat hospital-acquired infections in 2017, which is incorporated with engineered textile designs that are used on hospital doors in place of traditional aluminum door plates in order to encourage hand hygiene. Antibiotic resistance is a major factor associated with hospital-acquired disease testing. In 2012, Curetis Unyvero System launched a molecular device which is used for rapid detection of microorganism and antibiotic resistance gene.
Key takeaways of the market:
- The global hospital-acquired disease testing market is expected to exhibit a CAGR of 20.0% over the forecast period (2017–2025), owing to rising geriatric population. Asia Pacific is expected to exhibit a high growth rate, in terms of value in the global hospital-acquired disease testing market over the forecast period.
- Among test type, the urinary tract infection segment is expected to hold a major share in the market over the forecast period. This is due to prevalence of nosocomial infections which are caused by UTIs as they have higher antibiotic resistance compared to normal UTIs.
- The global hospital-acquired disease testing market is characterized by market expansion in Asia Pacific and Latin America, which is expected to generate higher market revenue, due to increasing incidence of hospital-acquired diseases.
Apply Promo Code “STAYHOME” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/992
Some of the major companies operating in the global hospital-acquired disease testing market are Diatherix Laboratories, Life Technologies, Cantel Medical Corporation Meridian Biosciences, Qiagen GmbH, Nordion, Roche, and Cepheid.
Other Related Reports:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
